Sign in
4

Changes in Ownership

Amneal Pharmaceuticals, Inc. Filed Acc 0001209191-23-054738

Co-CEO acquired 24,753,252 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Chintu Co-CEO 2023-11-07 Other acquisition +24,753,252 24,753,252 I
Derivatives
Patel Chintu Co-CEO 2023-11-07 Other disposition · Class B Common Stock and Common Units −24,753,252 0 I
Loading xslF345X05/doc4.xml…